Changes in inflammatory and vasoactive mediator profiles during valvular surgery with or without infective endocarditis: A case control pilot study
Mahmoud Diab, Raphael Tasar, Christoph Sponholz, Thomas Lehmann, Mathias W Pletz, Michael Bauer, Frank M Brunkhorst, Torsten Doenst, Mahmoud Diab, Raphael Tasar, Christoph Sponholz, Thomas Lehmann, Mathias W Pletz, Michael Bauer, Frank M Brunkhorst, Torsten Doenst
Abstract
Background: More than 50% of patients with infective endocarditis (IE) develop an indication for surgery. Despite its benefit, surgery is associated with a high incidence of multiple organ dysfunction syndrome (MODS) and mortality, which may be linked to increased release of inflammatory mediators during cardiopulmonary bypass (CPB). We therefore assessed plasma cytokine profiles in patients undergoing valve surgery with or without IE.
Methods: We performed a prospective case-control pilot study comparing patients undergoing cardiac valve surgery with or without IE. Plasma profiles of inflammatory mediators were measured at 7 defined time points and reported as median (interquartile). The degree of MODS was measured using sequential organ failure assessment (SOFA) score.
Results: Between May and December 2016 we included 40 patients (20 in each group). Both groups showed similar distribution of age and gender. Patients with IE had higher preoperative SOFA (6.9± 2.6 vs 3.8 ± 1.1, p<0.001) and operative risk scores (EuroSCORE II 18.6±17.4 vs. 1.8±1.3, p<0.001). In-hospital mortality was higher in IE patients (35% vs. 5%; p<0.001). Multiple organ failure was the cause of death in all non-survivors. At the end of CPB, median levels of following inflammatory mediators were higher in IE compared to control group: IL-6 (119.73 (226.49) vs. 24.48 (40.09) pg/ml, p = 0.001); IL-18 (104.82 (105.99) vs. 57.30 (49.53) pg/ml, p<0.001); Mid-regional pro-adrenomedullin (MR-proADM) (2.06 (1.58) vs. 1.11 (0.53) nmol/L, p = 0.003); MR- pro-atrial natriuretic peptide (MR-proANP) (479.49 (224.74) vs. 266.55 (308.26) pmol/l, p = 0.028). IL-1β and TNF- α were only detectable in IE patients and first after starting CPB. Plasma levels of IL-6, IL-18, MRproADM, and MRproANP during CPB were significantly lower in survivors than in those who died.
Conclusion: The presence of infective endocarditis during cardiac valve surgery is associated with increased inflammatory response as evident by higher plasma cytokine levels and other inflammatory mediators. Actively reducing inflammatory response appears to be a plausible therapeutic concept.
Trial registration: ClinicalTrials.gov, ID: NCT02727413.
Conflict of interest statement
All other authors declare no competing interests
Figures
References
- Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121(9):1141–52. 10.1161/CIRCULATIONAHA.108.773598
- Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132(3):1025–35. 10.1378/chest.06-2048
- Yew HS, Murdoch DR. Global trends in infective endocarditis epidemiology. Current infectious disease reports. 2012;14(4):367–72. 10.1007/s11908-012-0265-5
- Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr., Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of internal medicine. 2009;169(5):463–73. 10.1001/archinternmed.2008.603
- Galvez-Acebal J, Rodriguez-Bano J, Martinez-Marcos FJ, Reguera JM, Plata A, Ruiz J, et al. Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC infectious diseases. 2010;10:17 10.1186/1471-2334-10-17
- Gelsomino S, Maessen JG, van der Veen F, Livi U, Renzulli A, Luca F, et al. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. The Annals of thoracic surgery. 2012;93(5):1469–76. 10.1016/j.athoracsur.2011.11.025
- Musci M, Weng Y, Hubler M, Chavez T, Qedra N, Kosky S, et al. Predictors of early mortality in patients with active infective native or prosthetic aortic root endocarditis undergoing homograft aortic root replacement. Clinical research in cardiology: official journal of the German Cardiac Society. 2009;98(7):443–50.
- Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2002;21(2):232–44.
- Mota AL, Rodrigues AJ, Evora PR. [Adult cardiopulmonary bypass in the twentieth century: science, art or empiricism?]. Rev Bras Cir Cardiovasc. 2008;23(1):78–92. 10.1590/s0102-76382008000100013
- Bustamante J, Arevalo A, Tamayo E, Sarria C, Aguilar-Blanco EM, Heredia M, et al. Cytokine profiles linked to fatal outcome in infective prosthetic valve endocarditis. APMIS. 2014;122(6):526–9. 10.1111/apm.12189
- Araujo IR, Ferrari TC, Teixeira-Carvalho A, Campi-Azevedo AC, Rodrigues LV, Guimaraes Junior MH, et al. Cytokine Signature in Infective Endocarditis. PLoS One. 2015;10(7):e0133631 10.1371/journal.pone.0133631
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr., Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2000;30(4):633–8.
- Munzel U, Brunner E. Nonparametric methods in multivariate factorial designs. J Stat Plan Infer. 2000;88(1):117–32.
- Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardio-Thorac. 2002;21(2):232–44.
- Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Archives of internal medicine. 2007;167(15):1655–63. 10.1001/archinte.167.15.1655
- Bustamante-Munguira J, Arevalo A, Sarria C, Saez C, Aguilar-Blanco EM, Almansa R, et al. The Role of Pro-Inflammatory Cytokines in Late Prosthetic Valve Endocarditis. Brit J Surg. 2014;101:14–.
- Kern WV, Engel A, Schieffer S, Prummer O, Kern P. Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis. Infection and immunity. 1993;61(12):5413–6.
- Capo C, Amirayan N, Ghigo E, Raoult D, Mege J. Circulating cytokine balance and activation markers of leucocytes in Q fever. Clin Exp Immunol. 1999;115(1):120–3. 10.1046/j.1365-2249.1999.00786.x
- Bernardi MH, Rinoesl H, Dragosits K, Ristl R, Hoffelner F, Opfermann P, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery—a blinded, randomized, controlled pilot study using a novel adsorbent. Critical care. 2016;20:96 10.1186/s13054-016-1270-0
- Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, Chandrasekar B. Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury. Journal of Biological Chemistry. 2009;284(12):7853–65. 10.1074/jbc.M808824200
- Fisher CJ Jr., Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med. 1994;22(1):12–21. 10.1097/00003246-199401000-00008
- Elke G, Bloos F, Wilson DC, Meybohm P, Grp SCCT. Identification of developing multiple organ failure in sepsis patients with low or moderate SOFA scores. Critical care. 2018;22 10.1186/s13054-018-1946-8
- Ahmad T, Fiuzat M, Felker GM, O'Connor C. Novel biomarkers in chronic heart failure. Nature reviews Cardiology. 2012;9(6):347–59. 10.1038/nrcardio.2012.37
- Bahrmann P, Bahrmann A, Hofner B, Christ M, Achenbach S, Sieber CC, et al. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Eur Heart J Acute Cardiovasc Care. 2015;4(2):137–47. 10.1177/2048872614541904
- Bolignano D, Cabassi A, Fiaccadori E, Ghigo E, Pasquali R, Peracino A, et al. Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med. 2014;52(10):1447–56. 10.1515/cclm-2014-0379
- Hirata Y, Takata S, Kawahara Y, Takai Y, Chino N, Kimura T, et al. Molecular mechanism of action by atrial natriuretic peptide in rat vascular smooth muscle cells. Jpn Circ J. 1988;52(12):1430–5. 10.1253/jcj.52.1430
- Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Journal of the American College of Cardiology. 2010;55(19):2062–76. 10.1016/j.jacc.2010.02.025
- Guignant C, Venet F, Voirin N, Poitevin F, Malcus C, Bohe J, et al. Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1. Clin Chem Lab Med. 2010;48(12):1813–20. 10.1515/CCLM.2010.341
- Mcmurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma Endothelin in Chronic Heart-Failure. Circulation. 1992;85(4):1374–9. 10.1161/01.cir.85.4.1374
- Freeman BD, Machado FS, Tanowitz HB, Desruisseaux MS. Endothelin-1 and its role in the pathogenesis of infectious diseases. Life Sci. 2014;118(2):110–9. 10.1016/j.lfs.2014.04.021
- Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J. Endothelin in septic patients: Effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med. 2000;28(6):1854–60. 10.1097/00003246-200006000-00028
- Papassotiriou J, Morgenthaler NG, Struck J, Alonso C, Bergmann A. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem. 2006;52(6):1144–51. 10.1373/clinchem.2005.065581
- Buendgens L, Yagmur E, Bruensing J, Herbers U, Baeck C, Trautwein C, et al. C-terminal proendothelin-1 (CT-proET-1) is associated with organ failure and predicts mortality in critically ill patients. Journal of Intensive Care. 2017;5 10.1186/s40560-016-0201-0
- Liang Y, Li X, Zhang X, Li Z, Wang L, Sun Y, et al. Elevated levels of plasma TNF-alpha are associated with microvascular endothelial dysfunction in patients with sepsis through activating the NF-kappaB and p38 mitogen-activated protein kinase in endothelial cells. Shock. 2014;41(4):275–81. 10.1097/SHK.0000000000000116
- Bittar MN, Carey JA, Barnard JB, Pravica V, Deiraniya AK, Yonan N, et al. Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. The Annals of thoracic surgery. 2006;81(1):132–7. 10.1016/j.athoracsur.2005.07.037
- Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med. 1993;21(10 Suppl):S447–63.
- Frencken JF, van Vught LA, Peelen LM, Ong DSY, Klein Klouwenberg PMC, Horn J, et al. An Unbalanced Inflammatory Cytokine Response Is Not Associated With Mortality Following Sepsis: A Prospective Cohort Study. Crit Care Med. 2017;45(5):e493–e9. 10.1097/CCM.0000000000002292
- Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–74. 10.1038/nri3552
- Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II dagger. Eur J Cardio-Thorac. 2012;41(4):734–45.
- Remadi JP, Habib G, Nadji G, Brahim A, Thuny F, Casalta JP, et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. The Annals of thoracic surgery. 2007;83(4):1295–302. 10.1016/j.athoracsur.2006.09.093
- Diab M, Sponholz C, von Loeffelholz C, Scheffel P, Bauer M, Kortgen A, et al. Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients. Infection. 2017;45(6):857–66. 10.1007/s15010-017-1064-6
- Diab M, Guenther A, Sponholz C, Lehmann T, Faerber G, Matz A, et al. Pre-operative stroke and neurological disability do not independently affect short- and long-term mortality in infective endocarditis patients. Clinical Research in Cardiology. 2016;105(10):847–57. 10.1007/s00392-016-0993-x
Source: PubMed